Copyright Reports & Markets. All rights reserved.

Global Calcium Antagonists Sales Market Report 2021

Request for Sample of this report
Buy now

1 Calcium Antagonists Market Overview

  • 1.1 Calcium Antagonists Product Scope
  • 1.2 Calcium Antagonists Segment by Type
    • 1.2.1 Global Calcium Antagonists Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Dihydropyridine
    • 1.2.3 Diltiazem
    • 1.2.4 Verapamil
    • 1.2.5 Others
  • 1.3 Calcium Antagonists Segment by Application
    • 1.3.1 Global Calcium Antagonists Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hypertension
    • 1.3.3 Coronary Artery Disease
    • 1.3.4 Arrhythmia
    • 1.3.5 Ohers
  • 1.4 Calcium Antagonists Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Calcium Antagonists Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Calcium Antagonists Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Calcium Antagonists Price Trends (2016-2027)

2 Calcium Antagonists Estimates and Forecasts by Region

  • 2.1 Global Calcium Antagonists Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Calcium Antagonists Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Calcium Antagonists Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Calcium Antagonists Revenue Market Share by Region (2016-2021)
  • 2.3 Global Calcium Antagonists Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Calcium Antagonists Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Calcium Antagonists Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Calcium Antagonists Estimates and Projections (2016-2027)
    • 2.4.2 Europe Calcium Antagonists Estimates and Projections (2016-2027)
    • 2.4.3 China Calcium Antagonists Estimates and Projections (2016-2027)
    • 2.4.4 Japan Calcium Antagonists Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Calcium Antagonists Estimates and Projections (2016-2027)
    • 2.4.6 India Calcium Antagonists Estimates and Projections (2016-2027)

3 Global Calcium Antagonists Competition Landscape by Players

  • 3.1 Global Top Calcium Antagonists Players by Sales (2016-2021)
  • 3.2 Global Top Calcium Antagonists Players by Revenue (2016-2021)
  • 3.3 Global Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Antagonists as of 2020)
  • 3.4 Global Calcium Antagonists Average Price by Company (2016-2021)
  • 3.5 Manufacturers Calcium Antagonists Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Calcium Antagonists Market Size by Type

  • 4.1 Global Calcium Antagonists Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Calcium Antagonists Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Calcium Antagonists Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Calcium Antagonists Price by Type (2016-2021)
  • 4.2 Global Calcium Antagonists Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Calcium Antagonists Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Calcium Antagonists Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Calcium Antagonists Price Forecast by Type (2022-2027)

5 Global Calcium Antagonists Market Size by Application

  • 5.1 Global Calcium Antagonists Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Calcium Antagonists Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Calcium Antagonists Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Calcium Antagonists Price by Application (2016-2021)
  • 5.2 Global Calcium Antagonists Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Calcium Antagonists Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Calcium Antagonists Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Calcium Antagonists Price Forecast by Application (2022-2027)

6 North America Calcium Antagonists Market Facts & Figures

  • 6.1 North America Calcium Antagonists Sales by Company
    • 6.1.1 North America Calcium Antagonists Sales by Company (2016-2021)
    • 6.1.2 North America Calcium Antagonists Revenue by Company (2016-2021)
  • 6.2 North America Calcium Antagonists Sales Breakdown by Type
    • 6.2.1 North America Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 6.3 North America Calcium Antagonists Sales Breakdown by Application
    • 6.3.1 North America Calcium Antagonists Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Calcium Antagonists Sales Breakdown by Application (2022-2027)

7 Europe Calcium Antagonists Market Facts & Figures

  • 7.1 Europe Calcium Antagonists Sales by Company
    • 7.1.1 Europe Calcium Antagonists Sales by Company (2016-2021)
    • 7.1.2 Europe Calcium Antagonists Revenue by Company (2016-2021)
  • 7.2 Europe Calcium Antagonists Sales Breakdown by Type
    • 7.2.1 Europe Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Calcium Antagonists Sales Breakdown by Application
    • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Calcium Antagonists Market Facts & Figures

  • 8.1 China Calcium Antagonists Sales by Company
    • 8.1.1 China Calcium Antagonists Sales by Company (2016-2021)
    • 8.1.2 China Calcium Antagonists Revenue by Company (2016-2021)
  • 8.2 China Calcium Antagonists Sales Breakdown by Type
    • 8.2.1 China Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 8.3 China Calcium Antagonists Sales Breakdown by Application
    • 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Calcium Antagonists Market Facts & Figures

  • 9.1 Japan Calcium Antagonists Sales by Company
    • 9.1.1 Japan Calcium Antagonists Sales by Company (2016-2021)
    • 9.1.2 Japan Calcium Antagonists Revenue by Company (2016-2021)
  • 9.2 Japan Calcium Antagonists Sales Breakdown by Type
    • 9.2.1 Japan Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Calcium Antagonists Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Calcium Antagonists Market Facts & Figures

  • 10.1 Southeast Asia Calcium Antagonists Sales by Company
    • 10.1.1 Southeast Asia Calcium Antagonists Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Calcium Antagonists Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Calcium Antagonists Sales Breakdown by Type
    • 10.2.1 Southeast Asia Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Calcium Antagonists Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Calcium Antagonists Market Facts & Figures

  • 11.1 India Calcium Antagonists Sales by Company
    • 11.1.1 India Calcium Antagonists Sales by Company (2016-2021)
    • 11.1.2 India Calcium Antagonists Revenue by Company (2016-2021)
  • 11.2 India Calcium Antagonists Sales Breakdown by Type
    • 11.2.1 India Calcium Antagonists Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Calcium Antagonists Sales Breakdown by Type (2022-2027)
  • 11.3 India Calcium Antagonists Sales Breakdown by Application
    • 11.3.1 India Calcium Antagonists Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Calcium Antagonists Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Calcium Antagonists Business

  • 12.1 Pfizer
    • 12.1.1 Pfizer Corporation Information
    • 12.1.2 Pfizer Business Overview
    • 12.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Pfizer Calcium Antagonists Products Offered
    • 12.1.5 Pfizer Recent Development
  • 12.2 Aventis
    • 12.2.1 Aventis Corporation Information
    • 12.2.2 Aventis Business Overview
    • 12.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Aventis Calcium Antagonists Products Offered
    • 12.2.5 Aventis Recent Development
  • 12.3 Searle
    • 12.3.1 Searle Corporation Information
    • 12.3.2 Searle Business Overview
    • 12.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Searle Calcium Antagonists Products Offered
    • 12.3.5 Searle Recent Development
  • 12.4 Bayer
    • 12.4.1 Bayer Corporation Information
    • 12.4.2 Bayer Business Overview
    • 12.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bayer Calcium Antagonists Products Offered
    • 12.4.5 Bayer Recent Development
  • 12.5 AstraZeneca
    • 12.5.1 AstraZeneca Corporation Information
    • 12.5.2 AstraZeneca Business Overview
    • 12.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 AstraZeneca Calcium Antagonists Products Offered
    • 12.5.5 AstraZeneca Recent Development
  • 12.6 Knoll Pharmaceuticals
    • 12.6.1 Knoll Pharmaceuticals Corporation Information
    • 12.6.2 Knoll Pharmaceuticals Business Overview
    • 12.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Knoll Pharmaceuticals Calcium Antagonists Products Offered
    • 12.6.5 Knoll Pharmaceuticals Recent Development
  • 12.7 Wyeth-Ayerst
    • 12.7.1 Wyeth-Ayerst Corporation Information
    • 12.7.2 Wyeth-Ayerst Business Overview
    • 12.7.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Wyeth-Ayerst Calcium Antagonists Products Offered
    • 12.7.5 Wyeth-Ayerst Recent Development
  • 12.8 Novartis
    • 12.8.1 Novartis Corporation Information
    • 12.8.2 Novartis Business Overview
    • 12.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Novartis Calcium Antagonists Products Offered
    • 12.8.5 Novartis Recent Development
  • 12.9 Sanofi
    • 12.9.1 Sanofi Corporation Information
    • 12.9.2 Sanofi Business Overview
    • 12.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Sanofi Calcium Antagonists Products Offered
    • 12.9.5 Sanofi Recent Development
  • 12.10 Baiyunshan Pharmaceutical
    • 12.10.1 Baiyunshan Pharmaceutical Corporation Information
    • 12.10.2 Baiyunshan Pharmaceutical Business Overview
    • 12.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Products Offered
    • 12.10.5 Baiyunshan Pharmaceutical Recent Development
  • 12.11 South China Pharmaceutical Group
    • 12.11.1 South China Pharmaceutical Group Corporation Information
    • 12.11.2 South China Pharmaceutical Group Business Overview
    • 12.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 South China Pharmaceutical Group Calcium Antagonists Products Offered
    • 12.11.5 South China Pharmaceutical Group Recent Development
  • 12.12 Tianjin Tanabe Seiyaku
    • 12.12.1 Tianjin Tanabe Seiyaku Corporation Information
    • 12.12.2 Tianjin Tanabe Seiyaku Business Overview
    • 12.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Products Offered
    • 12.12.5 Tianjin Tanabe Seiyaku Recent Development

13 Calcium Antagonists Manufacturing Cost Analysis

  • 13.1 Calcium Antagonists Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Calcium Antagonists
  • 13.4 Calcium Antagonists Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Calcium Antagonists Distributors List
  • 14.3 Calcium Antagonists Customers

15 Market Dynamics

  • 15.1 Calcium Antagonists Market Trends
  • 15.2 Calcium Antagonists Drivers
  • 15.3 Calcium Antagonists Market Challenges
  • 15.4 Calcium Antagonists Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

    N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

    CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.

    Market Analysis and Insights: Global Calcium Antagonists Market
    The global Calcium Antagonists market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

    Global Calcium Antagonists Scope and Market Size
    The global Calcium Antagonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Calcium Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Dihydropyridine
    Diltiazem
    Verapamil
    Others

    Segment by Application
    Hypertension
    Coronary Artery Disease
    Arrhythmia
    Ohers

    The Calcium Antagonists market is analysed and market size information is provided by regions (countries). Segment by Application, the Calcium Antagonists market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Pfizer
    Aventis
    Searle
    Bayer
    AstraZeneca
    Knoll Pharmaceuticals
    Wyeth-Ayerst
    Novartis
    Sanofi
    Baiyunshan Pharmaceutical
    South China Pharmaceutical Group
    Tianjin Tanabe Seiyaku

    Buy now